Nevro Corp (NVRO)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Nevro Corp (NVRO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011515
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nevro Corp (Nevro) is a medical device company that offers therapeutic equipment. The company provides pain relief therapies for low back pain and other types of chronic pain. Its services include SCS therapy and clinical trials. Nevro’s SCS therapy is a low-frequency spinal cord stimulation therapy. The company uses implantable spinal cord stimulation system. It also develops high-frequency stimulation technology for chronic pain. Nevro offers HF10 therapy, a paresthesia free treatment to provide pain relief to patients. The company also conducts clinical and preclinical studies on back and leg pain. It serves the pain management needs of people. Nevro is headquartered in Redwood City, California, the US.

Nevro Corp (NVRO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nevro Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Nevro Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Nevro Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Nevro Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Nevro Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nevro Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Nevro Raises US$48 Million In Series C Financing 10
Nevro Secures US$58 Million In Financing 12
Equity Offering 14
Nevro Raises USD126 Million in Public Offering of Shares 14
Nevro Raises USD145 Million in IPO of Shares 16
Debt Offering 18
Nevro Completes Public Offering of 1.75% Notes Due 2021 for USD172.5 Million 18
Nevro Corp – Key Competitors 20
Nevro Corp – Key Employees 21
Nevro Corp – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Nov 06, 2017: Nevro Reports Third Quarter 2017 Financial Results 23
Aug 07, 2017: Nevro Reports Second Quarter 2017 Financial Results 24
May 08, 2017: Nevro Reports First Quarter 2017 Financial Results 25
Feb 23, 2017: Nevro Reports Fourth Quarter and Full Year 2016 Financial Results and Provides 2017 Outlook 26
Nov 07, 2016: Nevro Reports Third Quarter 2016 Financial Results 27
Aug 08, 2016: Nevro Reports Second Quarter 2016 Financial Results 28
May 09, 2016: Nevro Reports First Quarter 2016 Financial Results 29
Feb 29, 2016: Nevro Reports Fourth Quarter and Full Year 2015 Financial Results 30
Jan 11, 2016: Nevro Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2015 Revenue 32
Corporate Communications 33
Feb 29, 2016: Nevro Announces Executive Succession 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Nevro Corp, Medical Equipment, Key Facts, 2016 2
Nevro Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Nevro Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Nevro Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Nevro Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Nevro Corp, Deals By Market, 2011 to YTD 2017 8
Nevro Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nevro Raises US$48 Million In Series C Financing 10
Nevro Secures US$58 Million In Financing 12
Nevro Raises USD126 Million in Public Offering of Shares 14
Nevro Raises USD145 Million in IPO of Shares 16
Nevro Completes Public Offering of 1.75% Notes Due 2021 for USD172.5 Million 18
Nevro Corp, Key Competitors 20
Nevro Corp, Key Employees 21
Nevro Corp, Subsidiaries 22

★海外企業調査レポート[Nevro Corp (NVRO)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Boditech Med Inc (206640):企業の製品パイプライン分析2018
    Summary Boditech Med Inc (Boditech) is a medical device company that manufactures and distributes in-vitro diagnostic analyzers and reagents. The company’s products include ichroma Reader, a portable fluorescence scanning instrument and AFIAS-6, a next-generation fluorescence processing and scanning …
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd, is an upstream oil and gas exploration and production company. The company explores, produces, and develops, oil and gas properties in Trinidad and Tobago. It holds interests in projects such as South Palo Seco, New …
  • Banque Cantonale Vaudoise (Private Banking):企業の戦略・SWOT・財務情報
    Banque Cantonale Vaudoise (Private Banking) - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale Vaudoise (Private Banking) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Cheniere Energy Inc (Cheniere) is a midstream energy company that owns and operates LNG-related businesses. The company through its general partner, Cheniere Energy Partners, L.P. (Cheniere Partners) …
  • ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析
    ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • OMV Petrom SA (SNP):石油・ガス:M&Aディール及び事業提携情報
    Summary OMV Petrom SA (Petrom), a subsidiary of OMV AG, is an integrated energy company that explores for, develops and produces crude oil and natural gas. The company processes and refines crude oil and sells refined products. It conducts power generation and has considerable wind energy operations …
  • Apple Inc:企業の戦略・SWOT・財務情報
    Apple Inc - Strategy, SWOT and Corporate Finance Report Summary Apple Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Trilliant Holdings, Inc.:企業の戦略的SWOT分析
    Trilliant Holdings, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Orexo AB (ORX):企業の財務・戦略的SWOT分析
    Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • China Aerospace Science and Industry Corp:企業の戦略・SWOT・財務情報
    China Aerospace Science and Industry Corp - Strategy, SWOT and Corporate Finance Report Summary China Aerospace Science and Industry Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • TriMedx LLC:企業の戦略的SWOT分析
    TriMedx LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • East Central Energy:発電所・企業SWOT分析
    East Central Energy - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Jacquet Metal Service SA:企業の戦略・SWOT・財務情報
    Jacquet Metal Service SA - Strategy, SWOT and Corporate Finance Report Summary Jacquet Metal Service SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ABO Wind AG:企業の戦略的SWOT分析
    ABO Wind AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Toppan Forms Co Ltd
    Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Old National Bancorp:企業のM&A・事業提携・投資動向
    Old National Bancorp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Old National Bancorp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • BioTime Inc (BTX):医療機器:M&Aディール及び事業提携情報
    Summary BioTime Inc (BioTime) is a clinical-stage biotechnology company. It focuses on developing cures or treatments based on its core proprietary technology platforms for cell replacement and cell/drug delivery.The company's aesthetics products under development include Renevia , a potential treat …
  • Confluent Medical Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary Confluent Medical Technologies Inc (CMT), formerly Nitinol Devices and Components Inc is a medical device company that manufactures and markets nitinol devices and balloon catheters. The company’s products include wire, strip, sheet, tubing, and bar. Its development services include finite e …
  • Ultrapar Participacoes SA (UGPA3):企業の財務・戦略的SWOT分析
    Ultrapar Participacoes SA (UGPA3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cellmid Ltd (CDY):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆